Matches in Nanopublications for { ?s ?p "In the present study, cells from a poorly differentiated squamous cell carcinoma NPC cell line, CNE2, were stimulated by TPA and proteomics technology was carried out to find protein discrepancies between control and TPA-treated cells. Results revealed that TPA treatment in CNE2 cells could upregulate the expression of \"triosephosphate isomerase\" and \"14-3-3 protein sigma\" and downregulate the expression of \"reticulocalbin 1 precursor\", \"nucleophosmin\", \"mitochondrial matrix protein p1 precursor\", and \"stathmin\"." ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- _3 value "In the present study, cells from a poorly differentiated squamous cell carcinoma NPC cell line, CNE2, were stimulated by TPA and proteomics technology was carried out to find protein discrepancies between control and TPA-treated cells. Results revealed that TPA treatment in CNE2 cells could upregulate the expression of \"triosephosphate isomerase\" and \"14-3-3 protein sigma\" and downregulate the expression of \"reticulocalbin 1 precursor\", \"nucleophosmin\", \"mitochondrial matrix protein p1 precursor\", and \"stathmin\"." provenance.
- _5 value "In the present study, cells from a poorly differentiated squamous cell carcinoma NPC cell line, CNE2, were stimulated by TPA and proteomics technology was carried out to find protein discrepancies between control and TPA-treated cells. Results revealed that TPA treatment in CNE2 cells could upregulate the expression of \"triosephosphate isomerase\" and \"14-3-3 protein sigma\" and downregulate the expression of \"reticulocalbin 1 precursor\", \"nucleophosmin\", \"mitochondrial matrix protein p1 precursor\", and \"stathmin\"." provenance.
- _5 value "In the present study, cells from a poorly differentiated squamous cell carcinoma NPC cell line, CNE2, were stimulated by TPA and proteomics technology was carried out to find protein discrepancies between control and TPA-treated cells. Results revealed that TPA treatment in CNE2 cells could upregulate the expression of \"triosephosphate isomerase\" and \"14-3-3 protein sigma\" and downregulate the expression of \"reticulocalbin 1 precursor\", \"nucleophosmin\", \"mitochondrial matrix protein p1 precursor\", and \"stathmin\"." provenance.
- _5 value "In the present study, cells from a poorly differentiated squamous cell carcinoma NPC cell line, CNE2, were stimulated by TPA and proteomics technology was carried out to find protein discrepancies between control and TPA-treated cells. Results revealed that TPA treatment in CNE2 cells could upregulate the expression of \"triosephosphate isomerase\" and \"14-3-3 protein sigma\" and downregulate the expression of \"reticulocalbin 1 precursor\", \"nucleophosmin\", \"mitochondrial matrix protein p1 precursor\", and \"stathmin\"." provenance.
- _4 value "In the present study, cells from a poorly differentiated squamous cell carcinoma NPC cell line, CNE2, were stimulated by TPA and proteomics technology was carried out to find protein discrepancies between control and TPA-treated cells. Results revealed that TPA treatment in CNE2 cells could upregulate the expression of \"triosephosphate isomerase\" and \"14-3-3 protein sigma\" and downregulate the expression of \"reticulocalbin 1 precursor\", \"nucleophosmin\", \"mitochondrial matrix protein p1 precursor\", and \"stathmin\"." provenance.
- _5 value "In the present study, cells from a poorly differentiated squamous cell carcinoma NPC cell line, CNE2, were stimulated by TPA and proteomics technology was carried out to find protein discrepancies between control and TPA-treated cells. Results revealed that TPA treatment in CNE2 cells could upregulate the expression of \"triosephosphate isomerase\" and \"14-3-3 protein sigma\" and downregulate the expression of \"reticulocalbin 1 precursor\", \"nucleophosmin\", \"mitochondrial matrix protein p1 precursor\", and \"stathmin\"." provenance.